Cargando…

A risk score development for diabetic retinopathy screening in Isfahan-Iran

BACKGROUND: The purpose of this study was to develop a simple risk score as screening tool for retinopathy in type II diabetic patients. METHODS: A cross-sectional study was carried out recruiting 3734 patients with type II diabetes in an outpatient clinic in Isfahan Endocrinology and Metabolism Res...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Sayed Mohsen, Maracy, Mohammad Reza, Amini, Masoud, Baradaran, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications Pvt Ltd 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129085/
https://www.ncbi.nlm.nih.gov/pubmed/21772868
_version_ 1782207512490016768
author Hosseini, Sayed Mohsen
Maracy, Mohammad Reza
Amini, Masoud
Baradaran, Hamid Reza
author_facet Hosseini, Sayed Mohsen
Maracy, Mohammad Reza
Amini, Masoud
Baradaran, Hamid Reza
author_sort Hosseini, Sayed Mohsen
collection PubMed
description BACKGROUND: The purpose of this study was to develop a simple risk score as screening tool for retinopathy in type II diabetic patients. METHODS: A cross-sectional study was carried out recruiting 3734 patients with type II diabetes in an outpatient clinic in Isfahan Endocrinology and Metabolism Research Center (IEMRC), Iran. The logistic regression was used as a model to predict diabetic retinopathy. The cut-off value for the risk score was determined using the Receiver Operating Characteristic (ROC) curve procedure. RESULTS: According to final models, being male, having lower body mass index (BMI), being older, longer duration of diabetes and higher HbA1c were correlated with increased risk of diabetic retinopathy. Area under the Curve (ROC) was 0.704 (95% CI: 0.685-0.723). A value ≥ 52.5 had the optimum sensitivity (60%) and specificity (69%) for determining diabetic retinopathy. CONCLUSIONS: The results indicated that risk factors for retinopathy were sex, BMI, age, duration of diabetes and HbA1c levels. In conclusion, applying developed retinopathy risk score is a practical way to identify patients who are at high risk for developing diabetic retinopathy for an early treatment.
format Online
Article
Text
id pubmed-3129085
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-31290852011-07-19 A risk score development for diabetic retinopathy screening in Isfahan-Iran Hosseini, Sayed Mohsen Maracy, Mohammad Reza Amini, Masoud Baradaran, Hamid Reza J Res Med Sci Original Article BACKGROUND: The purpose of this study was to develop a simple risk score as screening tool for retinopathy in type II diabetic patients. METHODS: A cross-sectional study was carried out recruiting 3734 patients with type II diabetes in an outpatient clinic in Isfahan Endocrinology and Metabolism Research Center (IEMRC), Iran. The logistic regression was used as a model to predict diabetic retinopathy. The cut-off value for the risk score was determined using the Receiver Operating Characteristic (ROC) curve procedure. RESULTS: According to final models, being male, having lower body mass index (BMI), being older, longer duration of diabetes and higher HbA1c were correlated with increased risk of diabetic retinopathy. Area under the Curve (ROC) was 0.704 (95% CI: 0.685-0.723). A value ≥ 52.5 had the optimum sensitivity (60%) and specificity (69%) for determining diabetic retinopathy. CONCLUSIONS: The results indicated that risk factors for retinopathy were sex, BMI, age, duration of diabetes and HbA1c levels. In conclusion, applying developed retinopathy risk score is a practical way to identify patients who are at high risk for developing diabetic retinopathy for an early treatment. Medknow Publications Pvt Ltd 2009 /pmc/articles/PMC3129085/ /pubmed/21772868 Text en © Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hosseini, Sayed Mohsen
Maracy, Mohammad Reza
Amini, Masoud
Baradaran, Hamid Reza
A risk score development for diabetic retinopathy screening in Isfahan-Iran
title A risk score development for diabetic retinopathy screening in Isfahan-Iran
title_full A risk score development for diabetic retinopathy screening in Isfahan-Iran
title_fullStr A risk score development for diabetic retinopathy screening in Isfahan-Iran
title_full_unstemmed A risk score development for diabetic retinopathy screening in Isfahan-Iran
title_short A risk score development for diabetic retinopathy screening in Isfahan-Iran
title_sort risk score development for diabetic retinopathy screening in isfahan-iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3129085/
https://www.ncbi.nlm.nih.gov/pubmed/21772868
work_keys_str_mv AT hosseinisayedmohsen ariskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT maracymohammadreza ariskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT aminimasoud ariskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT baradaranhamidreza ariskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT hosseinisayedmohsen riskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT maracymohammadreza riskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT aminimasoud riskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran
AT baradaranhamidreza riskscoredevelopmentfordiabeticretinopathyscreeninginisfahaniran